Somatostatin receptor-binding peptides labeled with technetium-99m: Chemistry and initial biological studies

Journal of Medicinal Chemistry

Volumn 39, Issue 7, 1996, Pages 1361-1371

  Pearson, Daniel A ^a   Lister James, John ^a   McBride, William J ^a   Wilson, David M ^a   Martel, Lawrence J ^a   Civitello, Edgar R ^a   Taylor, John E ^b   Moyer, Brian R ^a   Dean, Richard T ^a  

^a BAYER PHARMA AG   (Germany)

^b Biomeasure Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; CHELATING AGENT; OCTREOTIDE; P 587; P 617; P 829; PENTETATE INDIUM IN 111; RADIOISOTOPE; RHENIUM COMPLEX; SEGLITIDE; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; TECHNETIUM 99M; TECHNETIUM COMPLEX; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; COMPLEX FORMATION; DIAGNOSTIC IMAGING; DRUG EXCRETION; HORMONE RECEPTOR INTERACTION; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; NONHUMAN; NUCLEAR MEDICINE; PEPTIDE SYNTHESIS; RAT; RECEPTOR BINDING; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TISSUE DISTRIBUTION; TUMOR MODEL;

AMINO ACID SEQUENCE; ANIMALS; CHELATING AGENTS; HUMANS; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; OCTREOTIDE; OLIGOPEPTIDES; PANCREATIC NEOPLASMS; PENTETIC ACID; PEPTIDES, CYCLIC; PROTEIN BINDING; RATS; RECEPTORS, SOMATOSTATIN; RHENIUM; SOMATOSTATIN; TECHNETIUM COMPOUNDS; TUMOR CELLS, CULTURED;

EID: 0029989477     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm950111m     Document Type: Article

References (34)

1. Brazeau, P.; Vale, W.; Burgus, R.; Ling, N.; Butcher, M.; Rivier, J.; Guillemin, R. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 1973, 179, 77-79.
2. Parmar, H.; Phillips, R. H.; Lightman, S. L. In Somatostatin Analogues: Mechanism of Action: Peptides in Oncology; Hffken, K., Ed.; Springer-Verlag: Heidelberg.
3. (a) Rens-Domiano, S.; Law, S. F.; Yamada, Y.; Seino, S.; Bell, G. I.; Reisine, T. Pharmacological properties of two cloned somatostatin receptors. Mol. Pharmacol. 1992, 42, 28-34.
4. (b) Yamada, Y.; Post, S. R.; Wang, K.; Tager, H. S.; Bell, G. I.; Seino, S. Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 251-255.
5. (c) Raynor, K.; Coy, D. C.; Reisine, T. Analogues of somatostatin bind selectively to brain somatostatin receptor subtypes. J. Neurochem. 1992, 59, 1241-1250.
6. Lamberts, S. W. J.; Koper, J. W.; Reubi, J.-C. Potential Role of Somatostatin Analogues in the Treatment of Cancer. Eur. J. Clin. Invest. 1987, 17, 281.
7. Lamberts, S. W. J.; Krenning, E. P.; Reubi, J.-C. The Role of Somatostatin and Its Analogs in the Diagnosis and Treatment of Tumors. Endocrine Rev. 1991, 12, 450-482.
8. Wangberg, B.; Nilsson, O.; Theodørsson, E.; Dahlstrøm, A.; Ahlman, H. The effect of a somatostatin analogue on the release of hormones from human midgut carcinoid tumor cells. Br. J. Cancer 1991, 64, 23-28.
9. Moreau, S. C.; Murphy, W. A.; Coy, D. H. Comparison of somatuline (BIM-23014) and somatostatin on endocrine and exocrine activities in the rat. Drug. Dev. Res. 1991, 22, 79-93.
10. Bauer, W.; Briner, U.; Doepfner, W.; Haller, R.; Huguenin, R.; Marbach, P.; Petcher, T. J.; Pless, J. SMS 201-995: A potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci. 1982, 31, 1133-1140.
11. 111In-DTPA-D-Phe]- Octreotide, A Potential Radiopharmaceutical for Imaging of Somatostatin Receptor-Potsitive Tumors: Synthesis, Radiolabeling and in vitro Validation. Life Sci. 1991, 49, 1593-1601.
12. 3]-Octreotide: The Rotterdam Experience with More Than 1000 Patients. Eur. J. Nucl. Med. 1993, 20, 716-731. Dorr, U.; Räth, U.; Sautter-Bihl, M.; Guzman, G.; Bach, D.; Adrian, H.; Bihl, H. Improved Visualization of Carcinoid Liver Metastases by Indium-111 Pentetreotide Scintigraphy Following Treatment with Cold Somatostatin Analogue. Eur. J. Nucl. Med. 1993, 20, 431-433.
13. 3]-Octreotide: The Rotterdam Experience with More Than 1000 Patients. Eur. J. Nucl. Med. 1993, 20, 716-731. Dorr, U.; Räth, U.; Sautter-Bihl, M.; Guzman, G.; Bach, D.; Adrian, H.; Bihl, H. Improved Visualization of Carcinoid Liver Metastases by Indium-111 Pentetreotide Scintigraphy Following Treatment with Cold Somatostatin Analogue. Eur. J. Nucl. Med. 1993, 20, 431-433.
14. 99mTc. Int. J. Nucl. Med. Biol. 1985, 12, 3-8.
15. Dean, R. T.; McBride, W.; Buttram, S. Technetium-99m labeled peptides for imaging. Patent WO 93/10747, 1993.
16. Veber, D. F. In Peptides - Synthesis-Structure-Function. Proceedings of the Seventh American Peptide Symposium; Rich, D., Gross, E., Eds.; Pierce Chemical Co.. Rockford, IL, 1981; pp 685-694.
17. Veber, D. F.; Saperstein, R.; Nutt, R. F.; Freidinger, R. M.; Brady, S. F.; Curley, P.; Perlow, D. S.; Paleveda, W. J.; Colton, C. D.; Zacchei, A. G.; Tocco, D. J.; Hoff, D. R.; Vandlen, R. L.; Gerich, J. E.; Hall, L.; Mandarino, L.; Cordes, E. H.; Anderson, P. S.; Hirschmann, R. A super active cyclic hexapeptide analog of somatostatin. Science 1984, 34, 1371-1378.
18. Spanevello, R. A.; Hirschmann, R.; Raynor, K.; Reisine, T.; Nutt, R. Synthesis of Novel, Highly Potent Cyclic-Hexapeptide Analogs of Somatostatin. Potential Application of Orthogonal Protection for Affinity Chromatography. Tetrahedron Lett. 1991, 32, 4675-4678.
19. van der Auwera, C.; Anteunix, M. J. O. N,N′-bis(2-oxo-3-oxazolidinyl)phosphinic chloride (BOP-Cl); a superb reagent for coupling at and with iminoacid residues. Int. J. Pept. Protein Res. 1987, 29, 574-588.
20. Courtoglou, V.; Gross, B.; Lambropoulou, V.; Zioudrou, C. O-Benzotriazolyl-N,N,N′,N′-tetramethyluronium Hexafluorophosphate as Coupling Reagent for the Synthesis of Peptides of Biological Interest. Synthesis 1984, 572-574.
21. (a) Pearson, D. A.; Baker, M. L.; Stone, C. A. Trialkylsilanes as scavengers in peptide synthesis. Tetrahedron Lett. 1989, 30, 2739-2742.
22. (b) Chan, W. C.; Bycroft, B. W. Deprotection of Arg-(Pmc)-containing peptides using TFA-trialkylsilane-methanol-EMS: Application to the synthesis of a prepeptide of nisin. In Peptides (Proc. 12th Am. Peptide Symp., June 16-21, 1991); Smith, J. A., Rivier, J. E., Eds.; ESCOM: Leiden, 1992; pp 613-614.
23. Bodansky, M. Principles of peptide synthesis, 2nd ed.; Springer-Verlag: Berlin, 1993; pp 1-329.
24. (a) Rink, H. Solid-phase synthesis of protected peptide fragments using a trialkoxydiphenyl-methyl ester resin. Tetrahedron Lett. 1987, 28, 3787-3790.
25. (b) Story, S. C.; Aldrich, J. V. Preparation of protected peptide amides using the Fmoc chemical protocal. Int. J. Pept. Protein Res. 1992, 39, 87-92.
26. 4. J. Inorg. Chem. 1966, 5, 9-16.
27. Bylund, D. B.; Yamamura, H. I. In Methods in Neurotransmitter Receptor Analysis; Yamamura, H. I., et al., Eds.; Raven Press: New York, 1990; pp 1-35.
28. 99mTc-labeled peptide and pertechnetate content. The solution of radiolabeled peptide is then used directly.
29. Thomas, R. W.; Estes, G.; Edler, C.; Deutsch, E. Technetium radiopharmaceutical development. 1. Synthesis, characterization, and structure of dichloro[hydrotris(1-pyrazolyl)borato]-oxotechnetium (V). J. Am. Chem. Soc. 1979, 101, 4581-4185.
30. (a) Kasina, S.; Fritzberg, A. R.; Johnson, D. L.; Eshima, D. Tissue distribution of technetium-99m-diamide dimercaptide complexes and potential use as renal pharmaceuticals. J. Med. Chem. 1986, 29, 1933-1940.
31. 3 as a hippuran replacement. J. Nucl. Med. 1986, 27, 111-116.
32. Stanfield, C. F.; Felix, A. M.; Danho, W. The Preparation of N-a-t-Boc-2,3-Diaminopropionic acid (DPR) and of N-a-t-Boc-2,4-Diaminobutyric Acid Derivatives Suitable for Solid-phase Peptide Synthesis. Org. Prep. Proc. Int. 1990, 22, 597-603.
33. User's Manual for the Applied Biosystems Model 431A Peptide Synthesizer, Version 2.00; January 1992; pp 3-50.
34. 11]Somatostatin-14 to Human Small Cell Lung Carcinoma (NCI-H69). Life Sci. 1988, 43, 421-427.